Friday, September 30, 2016

Bithiol




Bithiol may be available in the countries listed below.


Ingredient matches for Bithiol



Ichthammol

Ichthammol is reported as an ingredient of Bithiol in the following countries:


  • Belgium

International Drug Name Search

Cardio Aliv




Cardio Aliv may be available in the countries listed below.


Ingredient matches for Cardio Aliv



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Cardio Aliv in the following countries:


  • Peru

International Drug Name Search

Durodor




Durodor may be available in the countries listed below.


Ingredient matches for Durodor



Fentanyl

Fentanyl is reported as an ingredient of Durodor in the following countries:


  • Mexico

International Drug Name Search

Burinex




Burinex may be available in the countries listed below.


UK matches:

  • Burinex Tablets
  • Burinex 1mg Tablets (SPC)
  • Burinex 5mg Tablets (SPC)

Ingredient matches for Burinex



Bumetanide

Bumetanide is reported as an ingredient of Burinex in the following countries:


  • Australia

  • Austria

  • Belgium

  • Canada

  • Costa Rica

  • Denmark

  • Dominican Republic

  • El Salvador

  • France

  • Germany

  • Greece

  • Guatemala

  • Honduras

  • Hong Kong

  • Ireland

  • Luxembourg

  • Malta

  • Netherlands

  • New Zealand

  • Norway

  • Panama

  • Philippines

  • Singapore

  • Slovenia

  • South Africa

  • Sri Lanka

  • Sweden

  • Switzerland

  • Taiwan

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Bleo-Cell




Bleo-Cell may be available in the countries listed below.


Ingredient matches for Bleo-Cell



Bleomycin

Bleomycin sulfate (a derivative of Bleomycin) is reported as an ingredient of Bleo-Cell in the following countries:


  • Germany

International Drug Name Search

Brain Tumor Medications


Drugs associated with Brain Tumor

The following drugs and medications are in some way related to, or used in the treatment of Brain Tumor. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-topics

Topics under Brain Tumor

  • Anaplastic Astrocytoma (2 drugs)

  • Anaplastic Oligodendroglioma (5 drugs)

  • Angioblastoma (1 drug)

  • Glioblastoma Multiforme (5 drugs)

  • Malignant Glioma (3 drugs)

  • Pituitary Tumor (7 drugs in 3 topics)

Learn more about Brain Tumor





Drug List:

Benzylpenicillin Cooper




Benzylpenicillin Cooper may be available in the countries listed below.


Ingredient matches for Benzylpenicillin Cooper



Benzylpenicillin

Benzylpenicillin sodium (a derivative of Benzylpenicillin) is reported as an ingredient of Benzylpenicillin Cooper in the following countries:


  • Greece

International Drug Name Search

Brivirac




Brivirac may be available in the countries listed below.


Ingredient matches for Brivirac



Brivudine

Brivudine is reported as an ingredient of Brivirac in the following countries:


  • Italy

International Drug Name Search

Sildenafil Injection



Pronunciation: sil-DEN-a-fil
Generic Name: Sildenafil
Brand Name: Revatio Injection


Sildenafil Injection is used for:

Treating high blood pressure in the lungs (pulmonary arterial hypertension [PAH]). It may also be used for other conditions as determined by your doctor.


Sildenafil Injection is a phosphodiesterase type 5 (PDE5) inhibitor. It works by relaxing and dilating the blood vessels in the lungs. This lowers the blood pressure in the lungs and helps to improve your ability to exercise.


Do NOT use Sildenafil Injection if:


  • you are allergic to any ingredient in Sildenafil Injection

  • you have pulmonary veno-occlusive disease (PVOD)

  • you are taking nitrates (eg, isosorbide, nitroglycerin) in any form (eg, tablet, capsule, spray, patch, ointment), or nitroprusside

  • you take another medicine that contains sildenafil, another PDE5 inhibitor (eg, tadalafil, vardenafil), or ritonavir

  • you use certain recreational drugs called "poppers" (eg, amyl nitrate or nitrite, butyl nitrate or nitrite)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Sildenafil Injection:


Some medical conditions may interact with Sildenafil Injection. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of a prolonged (more than 4 hours) or painful erection (priapism)

  • if you have a deformed penis (eg, cavernosal fibrosis, Peyronie disease), certain blood cell problems (eg, leukemia, multiple myeloma, sickle cell anemia), or any other condition that may increase the risk of a prolonged or painful erection (priapism)

  • if you have a history of certain eye problems (eg, macular degeneration, optic neuropathy, retinitis pigmentosa, sudden vision loss in one or both eyes) or hearing problems (eg, ringing in the ears, decreased hearing, hearing loss)

  • if you are dehydrated or have a history of liver or kidney problems, high or low blood pressure, ulcers, bleeding problems, heart problems (eg, aortic stenosis, angina, irregular heartbeat, heart failure), blood vessel problems, or nervous system problems

  • if you have a history of a heart attack, a stroke, or life-threatening irregular heartbeat, especially within the past 6 months

  • if you have pulmonary hypertension caused by sickle cell anemia

  • if you are taking bosentan or medicine for erectile dysfunction (ED)

Some MEDICINES MAY INTERACT with Sildenafil Injection. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Alpha-blockers (eg, doxazosin), medicines for high blood pressure, nitrates (eg, isosorbide, nitroglycerin), or nitroprusside because severe low blood pressure with dizziness, light-headedness, and fainting may occur

  • Azole antifungals (eg, itraconazole, ketoconazole), H2 antagonists (eg, cimetidine), HIV protease inhibitors (eg, ritonavir, saquinavir), macrolide antibiotics (eg, erythromycin), or telithromycin because they may increase the risk of Sildenafil Injection's side effects

  • Barbiturates (eg, phenobarbital), bosentan, carbamazepine, efavirenz, nevirapine, phenytoin, rifabutin, or rifampin because they may decrease Sildenafil Injection's effectiveness

This may not be a complete list of all interactions that may occur. Ask your health care provider if Sildenafil Injection may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Sildenafil Injection:


Use Sildenafil Injection as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Sildenafil Injection is usually given as an injection at your doctor's office, hospital, or clinic. If you will be using Sildenafil Injection at home, a health care provider will teach you how to use it. Be sure you understand how to use Sildenafil Injection. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.

  • Do not use Sildenafil Injection if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.

  • Use Sildenafil Injection on a regular schedule to get the most benefit from it. Use it at the same times each day.

  • Continue to use Sildenafil Injection even if you feel well. Do not miss any doses.

  • Do not suddenly stop using Sildenafil Injection or change your dose without talking to your doctor.

  • Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.

  • If you miss a dose of Sildenafil Injection, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Sildenafil Injection.



Important safety information:


  • Sildenafil Injection may cause drowsiness, dizziness, fainting, or blurred vision. These effects may be worse if you use it with alcohol or certain medicines. Use Sildenafil Injection with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Sildenafil Injection may cause dizziness, light-headedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • Patients with heart problems who use Sildenafil Injection may be at increased risk of heart-related side effects, including a heart attack or stroke. Symptoms of a heart attack may include chest, shoulder, neck, or jaw pain; numbness of an arm or leg; severe dizziness, headache, nausea, stomach pain, or vomiting; fainting; or vision changes. Symptoms of a stroke may include confusion, vision or speech changes, one-sided weakness, or fainting. Contact your doctor or seek medical attention right away if you experience these symptoms.

  • Sildenafil Injection may rarely cause a prolonged (more than 4 hours) or painful erection. This could happen even when you are not having sex. If this is not treated right away, it could lead to permanent sexual problems, such as impotence. Contact your doctor right away if you have an erection that lasts more than 4 hours.

  • If vomiting or diarrhea occurs, you will need to take care not to become dehydrated. Contact your doctor for instructions.

  • Sildenafil Injection may uncommonly cause mild, temporary vision changes (eg, blurred vision, sensitivity to light, blue/green color tint to vision). Contact your doctor if vision changes persist or are severe.

  • Rarely, an eye problem called nonarteritic anterior ischemic optic neuropathy (NAION) has been reported in patients who took Sildenafil Injection. This may lead to decreased vision or permanent loss of vision in some cases. If you notice a sudden decrease in vision or loss of vision in one or both eyes, contact your doctor right away.

  • Sudden decreases in hearing and loss of hearing have been reported in some patients who have taken Sildenafil Injection. Sometimes they also noticed ringing in the ears or dizziness. If you notice a sudden decrease or loss of hearing, contact your doctor right away.

  • Do not use medicines or treatments for ED while you are using Sildenafil Injection without first checking with your doctor.

  • Use Sildenafil Injection with caution in the ELDERLY; they may be more sensitive to its effects.

  • Sildenafil Injection should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Sildenafil Injection while you are pregnant. It is not known if Sildenafil Injection is found in breast milk. If you are or will be breast-feeding while you use Sildenafil Injection, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Sildenafil Injection:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Diarrhea; dizziness; flushing; headache; mild pain, redness, or swelling at the injection site; muscle aches; nausea; nosebleed; numb or tingling skin; stuffy or runny nose; trouble sleeping; upset stomach.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; confusion; fainting; fast or irregular heartbeat; fever; memory loss; numbness of an arm or leg; one-sided weakness; painful or prolonged erection; persistent or severe pain, redness, or swelling at the injection site; ringing in the ears; seizure; severe or persistent dizziness or nosebleed; severe or persistent vision changes; shortness of breath; speech problems; sudden decrease or loss of hearing; sudden decrease or loss of vision in one or both eyes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Sildenafil side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include fainting; prolonged erection; severe dizziness.


Proper storage of Sildenafil Injection:

Sildenafil Injection is usually handled and stored by a health care provider. If you are using Sildenafil Injection at home, store Sildenafil Injection as directed by your pharmacist or health care provider. Keep Sildenafil Injection out of the reach of children and away from pets.


General information:


  • If you have any questions about Sildenafil Injection, please talk with your doctor, pharmacist, or other health care provider.

  • Sildenafil Injection is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Sildenafil Injection. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Sildenafil resources


  • Sildenafil Side Effects (in more detail)
  • Sildenafil Use in Pregnancy & Breastfeeding
  • Sildenafil Drug Interactions
  • Sildenafil Support Group
  • 53 Reviews for Sildenafil - Add your own review/rating


Compare Sildenafil with other medications


  • Erectile Dysfunction
  • Pulmonary Arterial Hypertension
  • Sexual Dysfunction, SSRI Induced

Bisoprolol comp.-CT




Bisoprolol comp.-CT may be available in the countries listed below.


Ingredient matches for Bisoprolol comp.-CT



Bisoprolol

Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Bisoprolol comp.-CT in the following countries:


  • Germany

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Bisoprolol comp.-CT in the following countries:


  • Germany

International Drug Name Search

Infracyanine




Infracyanine may be available in the countries listed below.


Ingredient matches for Infracyanine



Indocyanine Green

Indocyanine Green is reported as an ingredient of Infracyanine in the following countries:


  • France

International Drug Name Search

Bomba




Bomba may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Bomba



Bioallethrin

Bioallethrin is reported as an ingredient of Bomba in the following countries:


  • Portugal

Piperonyl Butoxide

Piperonyl Butoxide is reported as an ingredient of Bomba in the following countries:


  • Portugal

International Drug Name Search

Cefpodoxime Ratiopharm




Cefpodoxime Ratiopharm may be available in the countries listed below.


Ingredient matches for Cefpodoxime Ratiopharm



Cefpodoxime

Cefpodoxime proxetil (a derivative of Cefpodoxime) is reported as an ingredient of Cefpodoxime Ratiopharm in the following countries:


  • France

International Drug Name Search

Buprenodale




Buprenodale may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Buprenodale



Buprenorphine

Buprenorphine hydrochloride (a derivative of Buprenorphine) is reported as an ingredient of Buprenodale in the following countries:


  • Luxembourg

International Drug Name Search

Thursday, September 29, 2016

Crinohermal




Crinohermal may be available in the countries listed below.


Ingredient matches for Crinohermal



Estradiol

Estradiol is reported as an ingredient of Crinohermal in the following countries:


  • Germany

  • Luxembourg

Fluprednidene

Fluprednidene 21-acetate (a derivative of Fluprednidene) is reported as an ingredient of Crinohermal in the following countries:


  • Germany

  • Luxembourg

International Drug Name Search

Brucen




Brucen may be available in the countries listed below.


Ingredient matches for Brucen



Glibenclamide

Glibenclamide is reported as an ingredient of Brucen in the following countries:


  • Mexico

International Drug Name Search

Bupranololo




Bupranololo may be available in the countries listed below.


Ingredient matches for Bupranololo



Bupranolol

Bupranololo (DCIT) is also known as Bupranolol (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Benylin Dry Cough




Benylin Dry Cough may be available in the countries listed below.


Ingredient matches for Benylin Dry Cough



Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Benylin Dry Cough in the following countries:


  • South Africa

International Drug Name Search

Brivudine




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AB15

CAS registry number (Chemical Abstracts Service)

0069304-47-8

Chemical Formula

C11-H13-Br-N2-O5

Molecular Weight

333

Therapeutic Category

Antiviral agent

Chemical Name

(E)-5-(2-bromovinyl)-2'-deoxyuridine

Foreign Names

  • Brivudinum (Latin)
  • Brivudin (German)
  • Brivudine (French)
  • Brivudina (Spanish)

Brand Names

  • Bridic
    Menarini, Portugal


  • Brival
    Berlin-Chemie, Romania


  • Brivex
    Menarini, Switzerland


  • Brivir
    Berlin-Chemie, Bulgaria; Menarini, Greece


  • Brivirac
    Menarini, Italy


  • Brivox
    Menarini, Costa Rica; Menarini, Dominican Republic; Menarini, Guatemala; Menarini, Honduras; Menarini, Nicaragua; Menarini, Panama; Menarini, El Salvador


  • Brivumen
    Berlin-Chemie, Estonia; Berlin-Chemie, Lithuania; Berlin-Chemie, Latvia


  • Brivuzost
    Berlin-Chemie, Croatia (Hrvatska); Berlin-Chemie, Serbia


  • Menavir
    Berlin-Chemie, Germany


  • Mevir
    Guidotti, Austria


  • Nervinex
    Menarini, Spain


  • Premovir
    Berlin-Chemie, Germany; Berlin-Chemie, Poland; Sanolabor, Slovenia


  • Virocid
    Berlin Chemie, Bosnia & Herzegowina


  • Zecovir
    Guidotti, Italy


  • Zerpex
    Guidotti, Luxembourg; Menarini, Belgium; Menarini, Luxembourg


  • Zonavir
    Guidotti, Luxembourg; Menarini, Luxembourg


  • Zostevir
    Berlin-Chemie, Czech Republic


  • Zostex
    Berlin-Chemie, Germany; I.E. Ulagay, Turkey; Laboratori Guidotti, Austria


  • Zostydol
    Menarini, Argentina


  • Zovudex
    Berlin-Chemie, Slovakia

International Drug Name Search

Glossary

Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Bicalutamida QT Farma




Bicalutamida QT Farma may be available in the countries listed below.


Ingredient matches for Bicalutamida QT Farma



Bicalutamide

Bicalutamide is reported as an ingredient of Bicalutamida QT Farma in the following countries:


  • Spain

International Drug Name Search

Omeprazolo Hexal




Omeprazolo Hexal may be available in the countries listed below.


Ingredient matches for Omeprazolo Hexal



Omeprazole

Omeprazole is reported as an ingredient of Omeprazolo Hexal in the following countries:


  • Italy

International Drug Name Search

Doxycyclin AL




Doxycyclin AL may be available in the countries listed below.


Ingredient matches for Doxycyclin AL



Ambroxol

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Doxycyclin AL in the following countries:


  • Czech Republic

Doxycycline

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxycyclin AL in the following countries:


  • Germany

Doxycycline monohydrate (a derivative of Doxycycline) is reported as an ingredient of Doxycyclin AL in the following countries:


  • Czech Republic

  • Germany

  • Hungary

International Drug Name Search

Wednesday, September 28, 2016

Biafineact




Biafineact may be available in the countries listed below.


Ingredient matches for Biafineact



Trolamine

Trolamine is reported as an ingredient of Biafineact in the following countries:


  • France

International Drug Name Search

Quasense




In the US, Quasense (ethinyl estradiol/levonorgestrel systemic) is a member of the drug class contraceptives and is used to treat Abnormal Uterine Bleeding, Birth Control, Endometriosis, Gonadotropin Inhibition, Ovarian Cysts and Polycystic Ovary Syndrome.

US matches:

  • Quasense extended-cycle

  • Quasense

Ingredient matches for Quasense



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Quasense in the following countries:


  • United States

Levonorgestrel

Levonorgestrel is reported as an ingredient of Quasense in the following countries:


  • United States

International Drug Name Search

Blocadren Depot




Blocadren Depot may be available in the countries listed below.


Ingredient matches for Blocadren Depot



Timolol

Timolol maleate (a derivative of Timolol) is reported as an ingredient of Blocadren Depot in the following countries:


  • Iceland

  • Norway

International Drug Name Search

Bétahistine RPG




Bétahistine RPG may be available in the countries listed below.


Ingredient matches for Bétahistine RPG



Betahistine

Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Bétahistine RPG in the following countries:


  • France

International Drug Name Search

Beezocain




Beezocain may be available in the countries listed below.


Ingredient matches for Beezocain



Benzocaine

Benzocaine is reported as an ingredient of Beezocain in the following countries:


  • Japan

International Drug Name Search

Apo-Metoprolol-L




Apo-Metoprolol-L may be available in the countries listed below.


Ingredient matches for Apo-Metoprolol-L



Metoprolol

Metoprolol is reported as an ingredient of Apo-Metoprolol-L in the following countries:


  • Vietnam

International Drug Name Search

Seasonique


See also: Generic Seasonale


Seasonique is a brand name of ethinyl estradiol/levonorgestrel, approved by the FDA in the following formulation(s):


SEASONIQUE (ethinyl estradiol; levonorgestrel - tablet; oral)



  • Manufacturer: TEVA WOMENS

    Approval date: May 25, 2006

    Strength(s): 0.03MG,0.01MG;0.15MG,N/A [RLD][AB]

Has a generic version of Seasonique been approved?


A generic version of Seasonique has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Seasonique and have been approved by the FDA:


LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL (ethinyl estradiol; levonorgestrel tablet; oral)



  • Manufacturer: WATSON LABS

    Approval date: May 31, 2011

    Strength(s): 0.03MG,0.01MG;0.15MG,N/A [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Seasonique. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
    Patent 7,320,969
    Issued: January 22, 2008
    Inventor(s): Bell; Robert G. & Ben-Maimon; Carole & Iskold; Beata
    Assignee(s): Duramed Pharmaceuticals, Inc.
    This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
    Patent expiration dates:

    • January 30, 2024
      ✓ 
      Patent use: PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOD OF CONTRACEPTION




  • Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
    Patent 7,615,545
    Issued: November 10, 2009
    Inventor(s): Bell; Robert G. & Ben-Maimon; Carole & Iskold; Beata
    Assignee(s): Duramed Pharmaceuticals, Inc.
    This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
    Patent expiration dates:

    • June 15, 2023
      ✓ 
      Patent use: PREVENTION OF PREGNANCY




  • Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
    Patent 7,855,190
    Issued: December 21, 2010
    Inventor(s): Bell; Robert G. & Ben-Maimon; Carole S. & Iskold; Beata & Bronnenkant; Lance J. & Hait; Howard & Reape; Kathleen Z.
    Assignee(s): Teva Women's Health, Inc.
    The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Patent expiration dates:

    • December 5, 2028
      ✓ 
      Patent use: PREVENTION OF PREGNANCY




  • Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
    Patent 7,858,605
    Issued: December 28, 2010
    Inventor(s): Bell; Robert G. & Ben-Maimon; Carole & Iskold; Beata
    Assignee(s): Teva Women's Health, Inc.
    This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
    Patent expiration dates:

    • June 23, 2023
      ✓ 
      Drug product



See also...

  • Seasonique Consumer Information (Drugs.com)
  • Seasonique Consumer Information (Wolters Kluwer)
  • Seasonique extended-cycle Consumer Information (Cerner Multum)
  • Levonorgestrel/Ethinyl Estradiol Consumer Information (Wolters Kluwer)
  • Ethinyl estradiol and levonorgestrel Consumer Information (Cerner Multum)
  • Ethinyl estradiol and levonorgestrel extended-cycle Consumer Information (Cerner Multum)

Equibactin




Equibactin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Equibactin



Sulfadiazine

Sulfadiazine is reported as an ingredient of Equibactin in the following countries:


  • Austria

  • France

  • Poland

Trimethoprim

Trimethoprim is reported as an ingredient of Equibactin in the following countries:


  • Austria

  • France

  • Poland

International Drug Name Search

Brinerdin




Brinerdin may be available in the countries listed below.


Ingredient matches for Brinerdin



Clopamide

Clopamide is reported as an ingredient of Brinerdin in the following countries:


  • Bahrain

  • Oman

  • Slovenia

  • South Africa

  • Switzerland

Dihydroergocristine

Dihydroergocristine is reported as an ingredient of Brinerdin in the following countries:


  • Slovenia

  • South Africa

Dihydroergocristine mesilate (a derivative of Dihydroergocristine) is reported as an ingredient of Brinerdin in the following countries:


  • Bahrain

  • Oman

  • Switzerland

Reserpine

Reserpine is reported as an ingredient of Brinerdin in the following countries:


  • Bahrain

  • Oman

  • Slovenia

  • South Africa

  • Switzerland

International Drug Name Search

Tuesday, September 27, 2016

Amoxicilina Fecofar




Amoxicilina Fecofar may be available in the countries listed below.


Ingredient matches for Amoxicilina Fecofar



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilina Fecofar in the following countries:


  • Argentina

International Drug Name Search

NeoCitran Hustenstiller




NeoCitran Hustenstiller may be available in the countries listed below.


Ingredient matches for NeoCitran Hustenstiller



Butamirate

Butamirate citrate (a derivative of Butamirate) is reported as an ingredient of NeoCitran Hustenstiller in the following countries:


  • Switzerland

International Drug Name Search

Carbenin




Carbenin may be available in the countries listed below.


Ingredient matches for Carbenin



Betamipron

Betamipron is reported as an ingredient of Carbenin in the following countries:


  • Japan

Panipenem

Panipenem is reported as an ingredient of Carbenin in the following countries:


  • Japan

International Drug Name Search

Blocanol




Blocanol may be available in the countries listed below.


Ingredient matches for Blocanol



Timolol

Timolol maleate (a derivative of Timolol) is reported as an ingredient of Blocanol in the following countries:


  • Finland

International Drug Name Search

Vasomet




Vasomet may be available in the countries listed below.


Ingredient matches for Vasomet



Terazosin

Terazosin hydrochloride (a derivative of Terazosin) is reported as an ingredient of Vasomet in the following countries:


  • Japan

International Drug Name Search

Monday, September 26, 2016

Blocanol Depot




Blocanol Depot may be available in the countries listed below.


Ingredient matches for Blocanol Depot



Timolol

Timolol maleate (a derivative of Timolol) is reported as an ingredient of Blocanol Depot in the following countries:


  • Finland

International Drug Name Search

Perflunafene




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

S01KX

CAS registry number (Chemical Abstracts Service)

0000306-94-5

Chemical Formula

C10-F18

Molecular Weight

462

Therapeutic Category

Diagnostic agent

Chemical Name

Octadecafluorodecahydronaphtalene

Foreign Names

  • Perflunafenum (Latin)
  • Perflunafen (German)
  • Perflunafene (French)
  • Perflunafeno (Spanish)

Generic Names

  • Perflunafene (OS: BAN)
  • F-DC (IS)
  • Fluosol-DA (IS)
  • Perfluordecalin (IS)
  • PFD (IS)
  • PP 5 (IS)

Brand Name

  • DK-Line
    Abdi Ibrahim, Turkey

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Bexistar




Bexistar may be available in the countries listed below.


Ingredient matches for Bexistar



Ibuprofen

Ibuprofen is reported as an ingredient of Bexistar in the following countries:


  • Spain

International Drug Name Search

Rubrum




Rubrum may be available in the countries listed below.


Ingredient matches for Rubrum



Granisetron

Granisetron is reported as an ingredient of Rubrum in the following countries:


  • Venezuela

International Drug Name Search

Lowpres




Lowpres may be available in the countries listed below.


Ingredient matches for Lowpres



Clonidine

Clonidine hydrochloride (a derivative of Clonidine) is reported as an ingredient of Lowpres in the following countries:


  • Venezuela

International Drug Name Search

Péridys




Péridys may be available in the countries listed below.


Ingredient matches for Péridys



Domperidone

Domperidone is reported as an ingredient of Péridys in the following countries:


  • Benin

  • Burkina Faso

  • Cameroon

  • Central African Republic

  • Chad

  • Congo

  • Cote D'ivoire

  • France

  • Gabon

  • Guinea

  • Madagascar

  • Mali

  • Mauritania

  • Niger

  • Senegal

  • Togo

  • Zaire

International Drug Name Search

Bio-Glibenclamide




Bio-Glibenclamide may be available in the countries listed below.


Ingredient matches for Bio-Glibenclamide



Glibenclamide

Glibenclamide is reported as an ingredient of Bio-Glibenclamide in the following countries:


  • South Africa

International Drug Name Search

Buquinolate




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0005486-03-3

Chemical Formula

C20-H27-N-O5

Molecular Weight

361

Therapeutic Category

Antiprotozoal: Agent against coccidiosis

Chemical Name

3-Quinolinecarboxylic acid, 4-hydroxy-6,7-bis(2-methylpropoxy)-, ethyl ester

Foreign Names

  • Buquinolatum (Latin)
  • Buquinolat (German)
  • Buquinolate (French)
  • Buquinolato (Spanish)

Generic Names

  • Buquinolate (OS: USAN)
  • Buchinolatum (IS)
  • EU-1093 (IS)

Brand Names

  • Bonaid (Buquinolate and Lincomycin (veterinary use))
    Pharmacia & Upjohn vet, United States


  • Lincomix (Buquinolate and Lincomycin (veterinary use))
    Pharmacia & Upjohn vet, United States


  • Lincomycin & Buquinolate (Buquinolate and Lincomycin (veterinary use))
    Pharmacia & Upjohn vet, United States

International Drug Name Search

Glossary

ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Silbecor




Silbecor may be available in the countries listed below.


Ingredient matches for Silbecor



Sulfadiazine

Sulfadiazine silver (a derivative of Sulfadiazine) is reported as an ingredient of Silbecor in the following countries:


  • South Africa

International Drug Name Search

Bupivacain-Morfin SDA




Bupivacain-Morfin SDA may be available in the countries listed below.


Ingredient matches for Bupivacain-Morfin SDA



Bupivacaine

Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Bupivacain-Morfin SDA in the following countries:


  • Denmark

Morphine

Morphine hydrochloride (a derivative of Morphine) is reported as an ingredient of Bupivacain-Morfin SDA in the following countries:


  • Denmark

International Drug Name Search

Burnil




Burnil may be available in the countries listed below.


Ingredient matches for Burnil



Tetryzoline

Tetryzoline hydrochloride (a derivative of Tetryzoline) is reported as an ingredient of Burnil in the following countries:


  • Turkey

International Drug Name Search

Bupivacain-Fentanyl Sintetica




Bupivacain-Fentanyl Sintetica may be available in the countries listed below.


Ingredient matches for Bupivacain-Fentanyl Sintetica



Bupivacaine

Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Bupivacain-Fentanyl Sintetica in the following countries:


  • Switzerland

Fentanyl

Fentanyl citrate (a derivative of Fentanyl) is reported as an ingredient of Bupivacain-Fentanyl Sintetica in the following countries:


  • Switzerland

International Drug Name Search

Topcare All Day Allergy D





Dosage Form: tablet
Topco All Day Allergy D Drug Facts

Active ingredient (in each extended release tablet)


Cetirizine HCl 5 mg


Pseudoephedrine HCl 120 mg



Purpose


Antihistamine


Nasal Decongestant



Uses


  • temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose

  • sneezing

  • itchy, watery eyes

  • itching of the nose or throat

  • nasal congestion

  • reduces swelling of nasal passages

  • temporarily relieves sinus congestion and pressure

  • temporarily restores freer breathing through the nose


Warnings



Do not use


  • if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.

  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.


Ask a doctor before use if you have


  • heart disease

  • thyroid disease

  • diabetes

  • glaucoma

  • high blood pressure

  • trouble urinating due to an enlarged prostate gland

  • liver or kidney disease. Your doctor should determine if you need a different dose.


Ask a doctor or pharmacist before use if you are


taking tranquilizers or sedatives.



When using this product


  • do not use more than directed

  • drowsiness may occur

  • avoid alcoholic drinks

  • alcohol, sedatives, and tranquilizers may increase drowsiness

  • be careful when driving a motor vehicle or operating machinery


Stop use and ask a doctor if


  • an allergic reaction to this product occurs. Seek medical help right away.

  • you get nervous, dizzy, or sleepless

  • symptoms do not improve within 7 days or are accompanied by fever


If pregnant or breast-feeding:


  • if breast-feeding: not recommended

  • if pregnant: ask a health professional before use.


Keep out of reach of children.


In case of overdose, get medical help or contact a Poison Control Center right away.




Directions


  • do not break or chew tablet; swallow tablet whole










adults and children 12 years and overtake 1 tablet every 12 hours; do not take more than 2 tablets in 24 hours.
adults 65 years and overask a doctor
children under 12 years of ageask a doctor
consumers with liver or kidney diseaseask a doctor

Other information


  • store between 20° to 25°C (68° to 77°F)


Inactive ingredients


colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, talc, yellow iron oxide



Questions or comments?


1-888-423-0139



Principal Display Panel


Original Prescription Strength


12 Hour


All Day Allergy D


Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets, 5 mg/120 mg


antihistamine/nasal decongestant


Allergy & Congestion


12 Hour Relief of: Sneezing, Runny Nose, Sinus Pressure, Itchy, Watery Eyes, Itchy Throat or Nose, Nasal Congestion


Indoor & Outdoor Allergies


Actual Size


Compare to Zyrtec-D® active ingredients


All Day Allergy D Carton










Topcare All Day Allergy D 
cetirizine hcl, pseudoephedrine hcl  tablet, extended release










Product Information
Product TypeHUMAN OTC DRUGNDC Product Code (Source)36800-176
Route of AdministrationORALDEA Schedule    











Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CETIRIZINE HYDROCHLORIDE (CETIRIZINE)CETIRIZINE HYDROCHLORIDE5 mg
PSEUDOEPHEDRINE HYDROCHLORIDE (PSEUDOEPHEDRINE)PSEUDOEPHEDRINE HYDROCHLORIDE120 mg





Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found


















Product Characteristics
ColorWHITE (one side white one side light yellow)Scoreno score
ShapeROUNDSize12mm
FlavorImprint Code5029;5;120
Contains      






















Packaging
#NDCPackage DescriptionMultilevel Packaging
136800-176-532 BLISTER PACK In 1 CARTONcontains a BLISTER PACK
16 TABLET In 1 BLISTER PACKThis package is contained within the CARTON (36800-176-53)
236800-176-624 BLISTER PACK In 1 CARTONcontains a BLISTER PACK
26 TABLET In 1 BLISTER PACKThis package is contained within the CARTON (36800-176-62)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07717005/19/2008


Labeler - Topco Associates LLC (006935977)
Revised: 06/2009Topco Associates LLC




More Topcare All Day Allergy D resources


  • Topcare All Day Allergy D Side Effects (in more detail)
  • Topcare All Day Allergy D Use in Pregnancy & Breastfeeding
  • Topcare All Day Allergy D Drug Interactions
  • Topcare All Day Allergy D Support Group
  • 3 Reviews for Topcare All Day Allergy D - Add your own review/rating


Compare Topcare All Day Allergy D with other medications


  • Hay Fever

Bupverine




Bupverine may be available in the countries listed below.


Ingredient matches for Bupverine



Propiverine

Propiverine hydrochloride (a derivative of Propiverine) is reported as an ingredient of Bupverine in the following countries:


  • Japan

International Drug Name Search

Dermades




Dermades may be available in the countries listed below.


Ingredient matches for Dermades



Desonide

Desonide is reported as an ingredient of Dermades in the following countries:


  • Indonesia

International Drug Name Search

Burana




Burana may be available in the countries listed below.


Ingredient matches for Burana



Ibuprofen

Ibuprofen is reported as an ingredient of Burana in the following countries:


  • Estonia

  • Finland

  • Russian Federation

  • Sweden

International Drug Name Search

Enterobiasis Medications


Definition of Enterobiasis: A common intestinal parasitic infection which primarily affects children.

Drugs associated with Enterobiasis

The following drugs and medications are in some way related to, or used in the treatment of Enterobiasis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:

mycophenolate mofetil


mye-koe-FEN-oh-late MOE-fe-til


Oral route(Capsule;Tablet;Powder for Suspension)

Increased susceptibility to infection and the possible development of lymphoma may result from immunosuppression. Only physicians experienced in immunosuppressive therapy and management of organ transplant recipients should prescribe, and they should have complete information requisite for the follow-up of the patient. Female contraception must be used due to increased risk of congenital malformations and pregnancy loss .



Commonly used brand name(s)

In the U.S.


  • Cellcept

Available Dosage Forms:


  • Powder for Suspension

  • Capsule

  • Tablet

Therapeutic Class: Immune Suppressant


Uses For mycophenolate mofetil


Mycophenolate belongs to a group of medicines known as immunosuppressive agents. It is used with other medicines to lower the body's natural immunity in patients who receive organ transplants (e.g., kidney, heart, or liver).


When a patient receives an organ transplant, the body's white blood cells will try to get rid of (reject) the transplanted organ. Mycophenolate prevents the white blood cells from rejecting the transplanted organ.


mycophenolate mofetil is available only with your doctor's prescription.


Before Using mycophenolate mofetil


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For mycophenolate mofetil, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to mycophenolate mofetil or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of mycophenolate in children receiving kidney transplants. However, safety and efficacy have not been established in infants younger than 3 months of age.


Appropriate studies have not been performed on the relationship of age to the effects of mycophenolate in children receiving heart or liver transplants. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of mycophenolate in the elderly. However, elderly patients are more likely to have age-related liver, kidney, or heart problems, which may require caution and an adjustment in the dose for patients receiving mycophenolate.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersDStudies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy in a life threatening situation or a serious disease, may outweigh the potential risk.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking mycophenolate mofetil, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using mycophenolate mofetil with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Activated Charcoal

  • Adenovirus Vaccine Type 4, Live

  • Adenovirus Vaccine Type 7, Live

  • Aluminum Carbonate, Basic

  • Aluminum Hydroxide

  • Aluminum Phosphate

  • Azathioprine

  • Bacillus of Calmette and Guerin Vaccine, Live

  • Cholestyramine

  • Colesevelam

  • Colestipol

  • Dexlansoprazole

  • Dihydroxyaluminum Aminoacetate

  • Dihydroxyaluminum Sodium Carbonate

  • Esomeprazole

  • Influenza Virus Vaccine, Live

  • Lansoprazole

  • Magaldrate

  • Magnesium Carbonate

  • Magnesium Hydroxide

  • Magnesium Oxide

  • Magnesium Trisilicate

  • Measles Virus Vaccine, Live

  • Metronidazole

  • Mumps Virus Vaccine, Live

  • Norfloxacin

  • Omeprazole

  • Pantoprazole

  • Poliovirus Vaccine, Live

  • Rabeprazole

  • Rifampin

  • Rotavirus Vaccine, Live

  • Rubella Virus Vaccine, Live

  • Smallpox Vaccine

  • Typhoid Vaccine

  • Varicella Virus Vaccine

  • Yellow Fever Vaccine

Using mycophenolate mofetil with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Ciprofloxacin

  • Cyclosporine

  • Desogestrel

  • Dienogest

  • Drospirenone

  • Estradiol Cypionate

  • Estradiol Valerate

  • Ethinyl Estradiol

  • Ethynodiol Diacetate

  • Etonogestrel

  • Iron

  • Levonorgestrel

  • Medroxyprogesterone Acetate

  • Mestranol

  • Norelgestromin

  • Norethindrone

  • Norgestimate

  • Norgestrel

  • Sevelamer

  • Valacyclovir

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of mycophenolate mofetil. Make sure you tell your doctor if you have any other medical problems, especially:


  • Bone marrow problems (e.g., neutropenia) or

  • Stomach ulcers or bleeding—Use with caution. May make these conditions worse.

  • Infection—May decrease your ability to fight an infection.

  • Kelley-Seegmiller syndrome (rare genetic disease) or

  • Lesch-Nyhan syndrome (rare genetic disease)—Should not be used in patients with these conditions.

  • Kidney disease, severe—Use with caution. The effects may be increased because of slower removal of the medicine from the body.

  • Phenylketonuria (PKU)—The oral suspension contains aspartame (phenylalanine), which can make this condition worse.

Proper Use of mycophenolate mofetil


Take mycophenolate mofetil exactly as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. Taking too much may increase the chance of side effects, while taking too little may lead to rejection of your transplanted organ.


mycophenolate mofetil should come with a medication guide. Read and follow these instructions carefully. Ask your doctor if you have any questions.


It is best to take mycophenolate mofetil on an empty stomach, either one hour before or 2 hours after meals, unless your doctor tells you otherwise.


Mycophenolate capsules and tablets should be swallowed whole. Do not break, crush, open, or chew them.


It is important that you handle mycophenolate mofetil with care. Avoid inhaling the powder from the capsule or allowing the powder or the oral liquid to touch your skin or eyes. If the medicine gets on your skin, wash it thoroughly with soap and water. If the medicine gets in your eyes, wash them with plain water. Should a spill occur, wipe it up using paper towels wetted with water to remove the powder or liquid.


You should use the oral dispenser from the pharmacist to measure the correct amount of suspension. If you have any questions about this, ask your doctor or pharmacist.


Use only the brand of mycophenolate tablets that your doctor ordered. Different brands may not work the same way.


If you are also using antacids that contain aluminum or magnesium (such as Maalox® or Mylanta®), do not use them at the same time as mycophenolate. Use them 1 hour before or 2 hours after your dose. If you have questions, talk with your doctor about the best times to use your medicines.


Dosing


The dose of mycophenolate mofetil will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of mycophenolate mofetil. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage forms (capsules, suspension, or tablets):
    • For heart transplants:
      • Adults—1.5 grams two times a day.

      • Older adults—1.5 grams two times a day.

      • Children—Use and dose must be determined by your doctor.


    • For kidney transplants:
      • Adults—1 gram two times a day.

      • Older adults—1 gram two times a day.

      • Teenagers and children above 3 months of age—Dose is based on body size as determined by the doctor. The suspension dose is 600 milligrams (mg) per square meter [m(2)] two times a day. The capsules and tablets are given as 750 mg to 1 gram two times a day.

      • Infants younger than 3 months of age—Use and dose must be determined by your doctor.


    • For liver transplants:
      • Adults—1.5 grams two times a day.

      • Older adults—1.5 grams two times a day.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of mycophenolate mofetil, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


The oral suspension can also be kept in the refrigerator. Throw away any unused suspension after 60 days.


Precautions While Using mycophenolate mofetil


It is very important that your doctor check your progress at regular visits. Your doctor will do blood tests to make sure that mycophenolate is working properly and to check for unwanted effects.


Using mycophenolate mofetil while you are pregnant can harm your unborn baby. If you are a woman who can bear children, your doctor may give you a pregnancy test before you start using mycophenolate mofetil to make sure you are not pregnant. Your birth control pills may not work as well while you are using mycophenolate mofetil. You must use two forms of birth control together for 1 month before starting mycophenolate mofetil, for the entire time that you are being treated, and for 6 weeks after you receive your last dose of mycophenolate mofetil. Use birth control pills together with another form of birth control, such as a condom, diaphragm, or contraceptive foam or jelly. If you think you have become pregnant while using the medicine, tell your doctor right away.


Using mycophenolate mofetil may increase your risk of getting skin cancer or cancer of the lymph system (lymphoma). Talk to your doctor if you have concerns about this risk.


Use sunscreen or sunblock lotions with a sun protection factor (SPF) of at least 15 on a regular basis when you are outdoors. Wear protective clothing and hats and stay out of direct sunlight, especially between the hours of 10 a.m. and 3 p.m. Avoid sunlamps and tanning beds.


Mycophenolate can temporarily lower the number of white blood cells in your blood, which increases the chance of getting an infection. If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you have a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.


Mycophenolate may cause pure red cell aplasia (PRCA). This is a very rare condition where the body no longer makes red blood cells and the patient has severe anemia. Check with your doctor right away if you have a fever and sore throat; pale skin; unusual bleeding or bruising; or unusual tiredness or weakness.


mycophenolate mofetil may increase your risk of developing a serious and rare brain infection called progressive multifocal leukoencephalopathy (PML). Check with your doctor right away if you are having more than one of these symptoms: vision changes, loss of coordination, clumsiness, memory loss, difficulty speaking or understanding what others say, and weakness in the legs.


mycophenolate mofetil may increase your risk of developing a rare and serious virus infection called BK virus-associated nephropathy (BKVAN). The BK virus may affect how your kidneys work and cause a transplanted kidney to fail. Check with your doctor right away if you are having more than one of these symptoms: bloody urine; a decreased frequency or amount of urine; increased thirst; loss of appetite; lower back or side pain; nausea; swelling of the face, fingers, or lower legs; trouble with breathing; unusual tiredness or weakness; vomiting; or weight gain.


While you are receiving mycophenolate, and after you stop, do not have any immunizations (vaccinations) without your doctor's approval. Mycophenolate will lower your body's resistance and there is a chance you might get the infection the immunization is meant to prevent.


Do not stop taking mycophenolate mofetil without checking first with your doctor. Doing so may cause rejection of your transplanted organ. Your doctor will decide how long you should take mycophenolate mofetil.


Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.


mycophenolate mofetil Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Abdominal or stomach cramps or pain

  • black, tarry stools

  • bladder pain

  • bleeding gums

  • bloating or swelling of the face, arms, hands, lower legs, or feet

  • blood in the urine or stools

  • bloody or cloudy urine

  • blurred vision

  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings

  • chest pain

  • confusion

  • convulsions

  • cough or hoarseness

  • decreased urine

  • difficult or labored breathing

  • difficult, burning, or painful urination

  • dizziness

  • dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly

  • drowsiness

  • dry mouth

  • fainting

  • fast, slow, pounding, or irregular heartbeat or pulse

  • fever or chills

  • flushed, dry skin

  • frequent urge to urinate

  • fruit-like breath odor

  • headache

  • increased hunger

  • increased thirst

  • increased urination

  • irregular heartbeats

  • irregular pulse

  • irritability

  • lightheadedness

  • loss of appetite

  • lower back or side pain

  • mood changes

  • mood or mental changes

  • muscle cramps in the hands, arms, feet, legs, or face

  • muscle pain or cramps

  • muscle spasms (tetany) or twitching

  • nausea or vomiting

  • nervousness

  • numbness or tingling in the hands, feet, or lips

  • painful or difficult urination

  • pale skin

  • pinpoint red spots on the skin

  • pounding in the ears

  • rapid weight gain

  • rapid, shallow breathing

  • seizures

  • shortness of breath

  • sore throat

  • sores, ulcers, or white spots on the lips or in the mouth

  • stomach pain and bloating

  • sweating

  • swollen glands

  • tightness in the chest

  • tingling of the hands or feet

  • trembling

  • tremor

  • troubled breathing

  • troubled breathing with exertion

  • unexplained weight loss

  • unusual bleeding or bruising

  • unusual tiredness or weakness

  • unusual weight gain or loss

  • vomiting

  • weakness or heaviness of the legs

  • wheezing

Incidence not known
  • Back pain

  • bloating

  • constipation

  • convulsions

  • coughing or spitting up blood

  • darkened urine

  • general feeling of illness

  • indigestion

  • night sweats

  • pain

  • pains in the stomach, side, or abdomen, possibly radiating to the back

  • severe headache

  • sudden high fever or low-grade fever for months

  • tenderness

  • watery or bloody diarrhea

  • yellow eyes or skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Acid or sour stomach

  • belching

  • fear or nervousness

  • heartburn

  • lack or loss of strength

  • rash

  • sleeplessness

  • unable to sleep

  • weight loss

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: mycophenolate mofetil side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More mycophenolate mofetil resources


  • Mycophenolate mofetil Side Effects (in more detail)
  • Mycophenolate mofetil Use in Pregnancy & Breastfeeding
  • Drug Images
  • Mycophenolate mofetil Drug Interactions
  • Mycophenolate mofetil Support Group
  • 27 Reviews for Mycophenolate mofetil - Add your own review/rating


  • Mycophenolate Mofetil Prescribing Information (FDA)

  • Mycophenolate Mofetil MedFacts Consumer Leaflet (Wolters Kluwer)

  • CellCept Prescribing Information (FDA)

  • Cellcept Consumer Overview



Compare mycophenolate mofetil with other medications


  • Autoimmune Hepatitis
  • Bullous Pemphigoid
  • Cogan's Syndrome
  • Crohn's Disease
  • Dermatomyositis
  • Evan's Syndrome
  • Graft-versus-host disease
  • High Cholesterol
  • Inflammatory Bowel Disease
  • Multiple Sclerosis
  • Myasthenia Gravis
  • Nephrotic Syndrome
  • Organ Transplant, Rejection Prophylaxis
  • Pemphigoid
  • Pemphigus
  • Psoriatic Arthritis
  • Pulmonary Fibrosis
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Ulcerative Colitis
  • Uveitis